These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 32534647)

  • 1. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
    Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
    Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
    Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
    Mathers JC; Movahedi M; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans G; Maher ER; Bertario L; Bisgaard ML; Dunlop M; Ho JW; Hodgson S; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen H; Gerdes AM; Barker G; Crawford G; Elliott F; Pylvanainen K; Wijnen J; Fodde R; Lynch H; Bishop DT; Burn J;
    Lancet Oncol; 2012 Dec; 13(12):1242-9. PubMed ID: 23140761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.
    Mathers JC; Elliott F; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar RS; Seppälä TT; Thomas HJW; Sheth HJ; Pylvänäinen K; Reed L; Borthwick GM; Bishop DT; Burn J;
    Cancer Prev Res (Phila); 2022 Sep; 15(9):623-634. PubMed ID: 35878732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
    Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.
    Movahedi M; Bishop DT; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar RS; Side L; Scott RJ; Thomas HJ; Vasen HF; Burn J; Mathers JC
    J Clin Oncol; 2015 Nov; 33(31):3591-7. PubMed ID: 26282643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention in Lynch syndrome.
    Burn J; Mathers JC; Bishop DT
    Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
    N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
    Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
    Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Gaziano JM; Brotons C; Coppolecchia R; Cricelli C; Darius H; Gorelick PB; Howard G; Pearson TA; Rothwell PM; Ruilope LM; Tendera M; Tognoni G;
    Lancet; 2018 Sep; 392(10152):1036-1046. PubMed ID: 30158069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.
    Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES
    Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS; McCloskey C; McSkimming P; McConnachie A
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
    Hawkey C; Avery A; Coupland CAC; Crooks C; Dumbleton J; Hobbs FDR; Kendrick D; Moore M; Morris C; Rubin G; Smith M; Stevenson D;
    Lancet; 2022 Nov; 400(10363):1597-1606. PubMed ID: 36335970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
    Chen YX; Gao QY; Zou TH; Wang BM; Liu SD; Sheng JQ; Ren JL; Zou XP; Liu ZJ; Song YY; Xiao B; Sun XM; Dou XT; Cao HL; Yang XN; Li N; Kang Q; Zhu W; Xu HZ; Chen HM; Cao XC; Fang JY
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):267-275. PubMed ID: 31926918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and colorectal cancer prevention in Lynch syndrome.
    Chan AT; Lippman SM
    Lancet; 2011 Dec; 378(9809):2051-2. PubMed ID: 22036018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.